Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface

作者: Subbulakshmi Karthikeyan , Daniel D. Lantvit , Dam Hee Chae , Joanna E. Burdette

DOI: 10.18632/ONCOTARGET.11499

关键词: OvarySerous fluidSlugMutantBiologyGene knockdownOviductOvarian carcinomaCancer researchCadherin

摘要: // Subbulakshmi Karthikeyan 1 , Daniel D. Lantvit Dam Hee Chae Joanna E. Burdette Center for Biomolecular Sciences, Department of Medicinal Chemistry and Pharmacognosy, College Pharmacy, University Illinois at Chicago, IL 60607, USA Correspondence to: Burdette, email: joannab@uic.edu Keywords: high-grade serous ovarian carcinoma, p53 mutation, fallopian tube, tissue specific mutant transgenic mouse model, cadherins Received: March 24, 2016     Accepted: August 09, Published: 22, 2016 ABSTRACT High-grade cancer (HGSOC) is the most lethal gynecological malignancy may arise in either tube epithelium (FTE) or surface (OSE). A mutation reported 96% HGSOC, frequently R273 R248. The goal this study was to identify gene targets FTE that are altered by p53, but not OSE. Gene analysis revealed both R248 reduces CDH6 expression oviduct, detected murine OSE cells. R273H induced SLUG FOXM1 while R248W did induce only modestly increased FOXM1, which correlated with less migration as compared . An oviduct PAX8 Cre/+ /p53 R270H/+ model created confirmed vivo repressed sufficient stabilize alone. Overexpression null OVCAR5 cells decreased levels indicating a gain-of-function. knockdown oviductal restored repression ChIP direct binding on promoter. NSC59984, small molecule degrades rescued expression. In summary, expressed ovary, p53. further validations aide establishing markers inform upon cell origin high grade tumors.

参考文章(49)
Brandon-Luke L. Seagle, Chia-Ping Huang Yang, Kevin H. Eng, Monica Dandapani, Oluwatosin Odunsi-Akanji, Gary L. Goldberg, Kunle Odunsi, Susan Band Horwitz, Shohreh Shahabi, TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas Gynecologic Oncology. ,vol. 138, pp. 159- 164 ,(2015) , 10.1016/J.YGYNO.2015.04.039
Jiajun Zhu, Morgan A. Sammons, Greg Donahue, Zhixun Dou, Masoud Vedadi, Matthäus Getlik, Dalia Barsyte-Lovejoy, Rima Al-awar, Bryson W. Katona, Ali Shilatifard, Jing Huang, Xianxin Hua, Cheryl H. Arrowsmith, Shelley L. Berger, Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth Nature. ,vol. 525, pp. 206- 211 ,(2015) , 10.1038/NATURE15251
Suzanne M. Quartuccio, Subbulakshmi Karthikeyan, Sharon L. Eddie, Daniel D. Lantvit, Eoghainín Ó hAinmhire, Dimple A. Modi, Jian-Jun Wei, Joanna E. Burdette, Mutant p53 expression in fallopian tube epithelium drives cell migration International Journal of Cancer. ,vol. 137, pp. 1528- 1538 ,(2015) , 10.1002/IJC.29528
Sharon L. Eddie, Suzanne M. Quartuccio, Eoghainin Ó hAinmhire, Georgette Moyle-Heyrman, Dan D. Lantvit, Jian-Jun Wei, Barbara C. Vanderhyden, Joanna E. Burdette, Tumorigenesis and peritoneal colonization from fallopian tube epithelium. Oncotarget. ,vol. 6, pp. 20500- 20512 ,(2015) , 10.18632/ONCOTARGET.3985
Shengliang Zhang, Lanlan Zhou, Bo Hong, A Pieter J van den Heuvel, Varun V Prabhu, Noel A Warfel, Christina Leah B Kline, David T Dicker, Levy Kopelovich, Wafik S El-Deiry, None, Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. Cancer Research. ,vol. 75, pp. 3842- 3852 ,(2015) , 10.1158/0008-5472.CAN-13-1079
Cheng Zhang, Wang, Du, Wang, Wu, Wang, Wang, Cao, Hamid, Zhang, Recombinant human decorin suppresses liver HepG2 carcinoma cells by p21 upregulation. OncoTargets and Therapy. ,vol. 5, pp. 143- 152 ,(2012) , 10.2147/OTT.S32918
AP Hess, S Talbi, AE Hamilton, DM Baston-Buest, Mette Nyegaard, JC Irwin, F Barragan, JS Kruessel, A Germeyer, LC Giudice, None, The human oviduct transcriptome reveals an anti-inflammatory, anti-angiogenic, secretory and matrix-stable environment during embryo transit. Reproductive Biomedicine Online. ,vol. 27, pp. 423- 435 ,(2013) , 10.1016/J.RBMO.2013.06.013
Dimple A. Modi, Suhair Sunoqrot, Jason Bugno, Daniel D. Lantvit, Seungpyo Hong, Joanna E. Burdette, Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells Nanoscale. ,vol. 6, pp. 2812- 2820 ,(2014) , 10.1039/C3NR05042D
Pradip Raychaudhuri, Hyun Jung Park, FoxM1: A Master Regulator of Tumor Metastasis Cancer Research. ,vol. 71, pp. 4329- 4333 ,(2011) , 10.1158/0008-5472.CAN-11-0640